|
Ponezheva Zh.B., Akimkin V.G., Mannanova I.V., Ugleva S.V., Duganova S.E., Shabalina S.V.
Relationship between immunological parameters and the severity of liver fibrosis in patients with chronic hepatitis C
|
№1 / 2023
|
|
Omarova Kh.G., Makashova V.V., Ponezheva Zh.B.
The features of the course of HBV infection during antiviral therapy
|
№1 / 2022
|
|
Tkachenko L.I., Maleev V.V., Tsvetkovskaya T.N.
Role of obesity in the development of metabolic disorders, in the progression of liver fibrosis, and in the outcomes of antiviral therapy in patients with chronic hepatitis C
|
№1 / 2016
|
|
Semenova I.V., Ponezheva Zh.B., Maleev V.V.
Current views on liver fibrosis and its markers
|
№2 / 2015
|
|
Makashova V.V., Kuznetsov S.D., Floryanu A.I., Shabalina S.V.
The clinical and laboratory features of the natural course of chronic hepatitis C
|
№2 / 2014
|
|
Malova Е.S., Glazkova Е.Ya., Morozov V.G., Rybkina А.А., Morozov A.V., Safiullina N.Kh., Balmasova I.P.
Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C on the basis of routine laboratory indices
|
№1 / 2013
|
|
Kaliaskarova K.S., Tuganbekova S.K., Malova E.S., Glazkova E.Ya., Morozov V.G., Balmasova I.P.
Tumor necrosis factor-α and liver fibrosis in chronic hepatitis B and C patients belonging to different population groups in Kazakhstan
|
№3 / 2012
|
Русский
